Purple Biotech Ltd. (PPBT) stock
PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.56+0.07 (+4.70%)
Close on Nov 12, 2026Market cap $1.45MP/E 0.0Yield –
Purple Biotech enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Purple Biotech's enterprise value was -$8.77M on Nov 11, 2026, against -$7.34M a year earlier. Over the last 5 years it ranged from -$14.78M to -$3.71M, with a median of -$8.77M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$8.77M | – |
| 2025 | Dec 31, 2025 | -$7.34M | – |
| 2024 | Dec 31, 2024 | -$14.37M | – |
| 2023 | Dec 29, 2023 | -$14.77M | – |
| 2022 | Dec 30, 2022 | -$8.19M | – |
| 2021 | Dec 31, 2021 | -$6.41M | -286.8% |
| 2020 | Dec 31, 2020 | $3.43M | -60.9% |
| 2019 | Dec 31, 2019 | $8.77M | +526.9% |
| 2018 | Dec 31, 2018 | $1.40M | -78.0% |
| 2017 | Dec 29, 2017 | $6.37M | – |
| 2016 | Dec 30, 2016 | -$7.56M | – |
See a number that looks wrong?